Related references
Note: Only part of the references are listed.Expression of High Mobility Group Box Chromosomal Protein 1 and Its Modulating Effects on Downstream Cytokines in Systemic Lupus Erythematosus
Jie Li et al.
JOURNAL OF RHEUMATOLOGY (2010)
The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus
Angela Midgley et al.
ARTHRITIS AND RHEUMATISM (2009)
Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity
Ayumi Yoshizaki et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus
Hooi-Ming Lee et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Interferon-α2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes
Akiko Yamane et al.
BLOOD (2008)
Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: Involvement of HMGB1 in anti-DNA antibody-induced renal injury
Xiaoping Qing et al.
IMMUNOLOGY LETTERS (2008)
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE
Vilma Urbonaviciute et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2008)
Platelets prevent IFN-α/β-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus
Matteo Iannacone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The role of tumor necrosis factor-alpha in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS RESEARCH & THERAPY (2008)
High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
T. B. Niewold et al.
GENES AND IMMUNITY (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
Basic science for the clinician 42 - Handling the corpses: Apoptosis, necrosis, nucleosomes and (quite possibly) the immunopothogenesis of SLE
Leonard H. Sigal
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2007)
Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome
Monica Ek et al.
ARTHRITIS AND RHEUMATISM (2006)
High mobility group box 1 protein interacts with multiple Toll-like receptors
JS Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Increased-expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus
K Popovic et al.
ARTHRITIS AND RHEUMATISM (2005)
HMG proteins: dynamic players in gene regulation and differentiation
ME Bianchi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells
IE Dumitriu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cross-regulation of TNF and IFN-α in autoimmune diseases
AK Palucka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
HMGB1 is an endogenous immune adjuvant released by necrotic cells
P Rovere-Querini et al.
EMBO REPORTS (2004)
Induction of clinical autoimmune disease by therapeutic interferon-α
C Gota et al.
AUTOIMMUNITY (2003)
Pathogenesis of systemic lupus erythematosus
CC Mok et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity
R Kokkola et al.
ARTHRITIS AND RHEUMATISM (2003)
High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis
R Pullerits et al.
ARTHRITIS AND RHEUMATISM (2003)
High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine
N Taniguchi et al.
ARTHRITIS AND RHEUMATISM (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
High mobility group box chromosomal protein 1 - A novel proinflammatory mediator in synovitis
R Kokkola et al.
ARTHRITIS AND RHEUMATISM (2002)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
HMG1 and 2, and related 'architectural' DNA-binding proteins
JO Thomas et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Cutting edge: HMG-1 as a mediator of acute lung inflammation
E Abraham et al.
JOURNAL OF IMMUNOLOGY (2000)
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
U Andersson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
